Local Application of Tranexamic Acid in Plastic Surgery Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Aesthetic plastic surgery 2023 Vol.47(4) p. 1633-1643

Wang S, Yang J, Lin L

관련 도메인

Abstract

[BACKGROUND] According to recent evidence, the use of local tranexamic acid (TXA) during plastic surgery may lessen blood loss.

[OBJECTIVES] To comprehensively assess the use of local TXA during plastic surgery through a systematic review and meta-analysis of randomized controlled trials addressing these issues.

[METHODS] Four electronic databases, including PubMed, Web of Science, Embase and the Cochrane Library, were searched until December 12, 2022. Following meta-analyses, the mean difference (MD) or standardized mean difference (SMD) for blood loss volume (BLV), ΔHct, ΔHb and operation time were calculated when appropriate.

[RESULTS] Eleven randomized controlled trials were included in the qualitative synthesis, while 8 studies were included in the meta-analysis. Compared with the control group, the local TXA group showed a reduction in blood loss volume of -1.05 (p < 0.00001; 95% CI, -1.72 to -0.38). However, local TXA had a limited effect on reducing ΔHct, ΔHb and operation time. A meta-analysis was not performed because of heterogeneity in other outcomes; however, except for 1 study in which no significant difference was observed on POD 1, all studies showed significantly lower rates of postoperative ecchymosis after surgery, 2 studies showed statistically significant reductions in transfusion risk or volume, and 3 studies reported significantly better surgical field quality in operations with local TXA. In the 2 included studies, the researchers concluded that local treatment does not play a role in relieving postoperative pain.

[CONCLUSIONS] Local TXA is associated with less blood loss, less ecchymosis and better surgical field in plastic surgery patients.

[LEVEL OF EVIDENCE I] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
약물 txa 트라넥삼산 dict 6
약물 tranexamic acid 트라넥삼산 dict 2
해부 blood scispacy 1
해부 ΔHb scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 blood loss C0019080
Hemorrhage
scispacy 1
질환 blood loss volume (BLV), ΔHct, ΔHb and operation time were calculated when appropriate. scispacy 1
질환 ecchymosis C0013491
Ecchymosis
scispacy 1
질환 postoperative pain C0030201
Pain, Postoperative
scispacy 1
기타 Patients scispacy 1
기타 BLV → blood loss volume scispacy 1
기타 POD 1 scispacy 1

MeSH Terms

Humans; Tranexamic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Surgery, Plastic; Ecchymosis; Randomized Controlled Trials as Topic

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문